Patents Assigned to Merck Patents GmbH
  • Publication number: 20210198365
    Abstract: Methods of administering a therapeutically effective amount of Debio 1143 and a therapeutically effective amount of an anti-PD-L1 antibody or antigen-binding fragment thereof, for the treatment of cancer, are provided.
    Type: Application
    Filed: October 19, 2018
    Publication date: July 1, 2021
    Applicants: Merck Patent GmbH, Pfizer Inc.
    Inventors: Grégoire Vuagniaux, Norbert Wiedemann, Claudio Zanna
  • Publication number: 20210198421
    Abstract: The invention relates to novel organic semiconducting (OSC) compounds containing one or more ester-substituted 4,8-dithiophenyl-benzodithiophene units or derivatives thereof, to methods for their preparation and educts or intermediates used therein, to compositions and formulations containing them, to the use of the compounds and compositions as organic semiconductors in, or for the preparation of, organic electronic (OE) devices, especially organic photovoltaic (OPV) devices, perovskite-based solar cell (PSC) devices, organic photodetectors (OPD), organic field effect transistors (OFET) and organic light emitting diodes (OLED), and to OE devices comprising these compounds or compositions.
    Type: Application
    Filed: April 16, 2019
    Publication date: July 1, 2021
    Applicants: MERCK PATENT GMBH
    Inventors: Jianhui HOU, Cunbin AN, Graham MORSE, Agnieszka PRON, Ignasi BURGUES
  • Publication number: 20210198233
    Abstract: Compounds of the formula I in which R1 denotes A, Ar, Cyc, Het, COA or CN, R2 denotes SO2A, SOA, SA, SO2NHA, SO2NA2, S(?NH,?O)A, S(?NH)2A, NO2, Hal, CN, A, Het1, COOH or COOA, R3 denotes H or Hal, R4 denotes H or Hal, n denotes 1, 2 or 3, A denotes unbranched or branched alkyl having 1-6 C-atoms, Cyc denotes cyclic alkyl with 3 to 7 C-atoms, Ar denotes phenyl, Het denotes a mono- or bicyclic aromatic, unsaturated or saturated heterocycle having 1 to 4 N, O, and/or S atoms, Het1 denotes a mono- or bicyclic aromatic, unsaturated or saturated heterocycle having 1 to 4 N, O, and/or S atoms, and Hal denotes F, Cl, Br, or I, are inhibitors of HIF-2?, and can be employed for the treatment of diseases such as cancer.
    Type: Application
    Filed: May 15, 2019
    Publication date: July 1, 2021
    Applicants: Merck Patent GmbH, Ryvu Therapeutics S.A.
    Inventors: Matthias Leiendecker, Hans-Peter Buchstaller
  • Patent number: 11045550
    Abstract: The present invention relates to the use of an amino sugar as plasticizer in formulations comprising a polymer as carrier for active ingredients, in particular for compositions which are intensively mixed by treatment in a melt extrusion and then formulated by suitable post-treatment.
    Type: Grant
    Filed: May 10, 2017
    Date of Patent: June 29, 2021
    Assignee: Merck Patent GmbH
    Inventors: Dieter Lubda, Mengyao Zheng, Alessandro Elia, Nicole Di Gallo, Anja-Nadine Knuettel
  • Patent number: 11046884
    Abstract: The present invention relates to formulations containing at least one organic functional material and at least a first organic solvent, wherein said first organic solvent contains at least one epoxy-group as well as to electronic devices prepared by using these formulations.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: June 29, 2021
    Assignee: Merck Patent GmbH
    Inventors: Li Wei Tan, Pawel Miskiewicz, Philip Edward May, Daniel Walker
  • Patent number: 11046700
    Abstract: The present invention relates to compounds of formula (1a), formula (1b), formula (1c) or formula (1d): or, or a pharmaceutically acceptable salt thereof, which have activity as inhibitors of Schistosoma growth. The invention also relates to pharmaceutical compositions comprising such compounds, salts or solvates and to the use of such compounds as medicaments, in particular in the treatment or prevention of schistosomiasis, also known as bilharzia.
    Type: Grant
    Filed: January 15, 2018
    Date of Patent: June 29, 2021
    Assignee: Merck Patent GmbH
    Inventors: John Mark Francis Gardner, Andrew Simon Bell
  • Patent number: 11047778
    Abstract: A sample preparation device (1) comprising a first chamber (2) containing a membrane support (30) on which a membrane (9) is placed or can be placed, an inlet (20) to the first chamber (2) and an outlet (21) from the first chamber (2), at least one second chamber (3) provided with or adapted to be provided with an anaerobic generation means (23) and/or an anaerobic detection indicator, wherein the at least one second chamber (3) is connected to the first chamber (2) by a communication path (8), wherein the communication path (8) is liquid-tightly closed by a tap device (4) in a first position (A) of the tap device (4) and is adapted to be opened to allow fluid communication between the first chamber (2) and the at least one second chamber (3) in that the tap device (4) is moved to a second position (B) of the tap device (4).
    Type: Grant
    Filed: October 13, 2016
    Date of Patent: June 29, 2021
    Assignee: MERCK PATENT GMBH
    Inventors: Stephane Olivier, Fabrice Comini
  • Publication number: 20210189241
    Abstract: A liquid-crystalline medium, preferably having a nematic phase and dielectric anisotropy of 0.5 or more, which comprises one or more compounds of each of formulae T and L in which the parameters have the meanings given in the claims and in the text. The use thereof in an electro-optical display, particularly in an active-matrix display based on the IPS or FFS effect, to displays of this type which contain a liquid-crystalline medium of this type. Also, the compounds of formulae T and L and their use for the improvement of the transmission and/or response times of a liquid-crystalline medium which comprises one or more additional mesogenic compounds.
    Type: Application
    Filed: December 18, 2020
    Publication date: June 24, 2021
    Applicant: Merck Patent GmbH
    Inventors: Atsutaka MANABE, Constanze BROCKE, Sebastian HOFMEYER
  • Publication number: 20210193879
    Abstract: The present invention relates to a process for manufacturing an optoelectronic device, wherein a layer of a formulation containing a silazane polymer and a wavelength converting material is applied to an optoelectronic device precursor, precured by exposure to radiation and then cured. There is further provided an optoelectronic device, preferably a light emitting device (LED) or a micro-light emitting device (micro-LED), which is prepared by said manufacturing process.
    Type: Application
    Filed: October 10, 2018
    Publication date: June 24, 2021
    Applicant: Merck Patent GmbH
    Inventors: Ralf GROTTENMUELLER, Abraham CASAS GARCIA-MINGUILLAN, Fumio KITA, Christoph LANDMANN, Fabian BLUMENSCHEIN
  • Patent number: 11040012
    Abstract: The present invention relates to premixes for the production of active compound-containing tablets which comprise polyvinyl alcohols (PVAs). The invention also relates to active compound-containing tablets which comprise a corresponding premix.
    Type: Grant
    Filed: July 3, 2015
    Date of Patent: June 22, 2021
    Assignee: Merck Patent GmbH
    Inventors: Roberto Ognibene, Finn Bauer, Thorsten Wedel, Guenter Moddelmog
  • Patent number: 11040990
    Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.
    Type: Grant
    Filed: February 14, 2018
    Date of Patent: June 22, 2021
    Assignee: Merck Patent GmbH
    Inventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
  • Patent number: 11042091
    Abstract: The present invention relates to a composition comprising; components a. c. and d; and optional component b. wherein, component a. is a metal compound having the structure (I), optional component b., is a polyol additive, having structure (VI), component c. is a high performance polymer additive, and component d. is a solvent. The present invention further relates to using this compositions in methods for manufacturing electronic devices through either the formation of a patterned films of high K material comprised of a metal oxide on a semiconductor substrate, or through the formation of patterned metal oxide comprised layer overlaying a semiconductor substrate which may be used to selectively etch the semiconductor substrate with a fluorine plasma.
    Type: Grant
    Filed: September 4, 2018
    Date of Patent: June 22, 2021
    Assignee: Merck Patent GmbH
    Inventors: Huirong Yao, JoonYeon Cho, M. Dalil Rahman
  • Patent number: 11041083
    Abstract: The present invention relates to formulations containing at least one organic functional material and at least a first organic solvent, wherein said first organic solvent is an alkyl benzoate solvent, as well as to electronic devices prepared by using these formulations.
    Type: Grant
    Filed: June 13, 2017
    Date of Patent: June 22, 2021
    Assignee: Merck Patent GmbH
    Inventors: Gaëlle Béalle, Christoph Leonhard, Hsin-Rong Tseng, Manuel Hamburger, Anja Jatsch, Philip May, Dietmar Kunkel, Irina Martynova, Edgar Kluge
  • Publication number: 20210179942
    Abstract: The present invention relates to a liquid crystal (LC) medium comprising a compound of formula I and one or more compounds selected from the group of compounds of the formulae IIA, IIB, IIC and IID, as defined in claim 1, and to the use of the LC medium for optical, electro-optical and electronic purposes, in particular in LC displays, especially in IPS, FFS, VA or PS-VA displays.
    Type: Application
    Filed: December 16, 2020
    Publication date: June 17, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Kaja Christina DEING, Sven Christian LAUT, Monika BAUER, Sebastian HOFMEYER, Kristin WEISS
  • Publication number: 20210181585
    Abstract: Devices for the regulation of light transmission and in particular switchable windows, including window elements containing a switchable optical cell having a homeotropically aligned liquid crystal layer with a pretilt angle in the range of 77° to 88°.
    Type: Application
    Filed: December 15, 2020
    Publication date: June 17, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Michael JUNGE, Rainer NEEFF
  • Publication number: 20210179856
    Abstract: BiOCl pigments coated with an amorphous carbon. A process for the preparation of the pigments. And use of the pigments prepared in this way, inter alia in paints, coatings, printing inks, plastics and cosmetics.
    Type: Application
    Filed: December 10, 2020
    Publication date: June 17, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Adeliene SCHMITT, Padma KAVIRATNA, Udo GUMSHEIMER, Mark TELLEFSEN, Qingmin CHENG
  • Publication number: 20210179881
    Abstract: The present invention relates to an oxidation-stable silver paste comprising silver nanoparticles, and to the use of a paste of this type for the production of decoration elements having a metallic luster on articles having an outer silicate surface, such as porcelain, ceramic, bone china, glass or enamel, to metallic coatings on such substrates and to a process for the production of coatings of this type.
    Type: Application
    Filed: December 11, 2020
    Publication date: June 17, 2021
    Applicant: Merck Patent GmbH
    Inventors: Anja KILIAN, Lydia MALLIG, Khwan Khung LIM
  • Patent number: 11035484
    Abstract: The invention provides a water purification and dispensing system, preferably for producing ultrapure water and offering the purified water at one or more dispensing sites in a desired volume.
    Type: Grant
    Filed: February 21, 2018
    Date of Patent: June 15, 2021
    Assignee: Merck Patent GmbH
    Inventors: Pascal Roitel, Christophe Paragot, Laurent Moreau
  • Patent number: 11033547
    Abstract: The invention relates to carboxamide-pyrimidine derivatives of the general formula I, or a pharmaceutically acceptable salt thereof, and the use of the compounds of the present invention for the treatment of hyperproliferative diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
    Type: Grant
    Filed: March 9, 2020
    Date of Patent: June 15, 2021
    Assignee: Merck Patent GmbH
    Inventors: Catherine Jorand-LeBrun, Roch Boivin, Igor Mochalkin, Theresa Johnson, Nina Linde, Doreen Musch, Deepak Kumar
  • Patent number: D922518
    Type: Grant
    Filed: February 14, 2019
    Date of Patent: June 15, 2021
    Assignee: MERCK PATENT GmbH
    Inventors: Laurent Moreau, Thierry Cassou